3/11
11:30 am
rapp
Rapport Therapeutics (RAPP) had its price target raised by Wells Fargo & Company from $43.00 to $46.00. They now have an "overweight" rating on the stock.
Low
Report
Rapport Therapeutics (RAPP) had its price target raised by Wells Fargo & Company from $43.00 to $46.00. They now have an "overweight" rating on the stock.
3/10
10:15 am
rapp
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
Medium
Report
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
3/10
07:30 am
rapp
Rapport Therapeutics GAAP EPS of -$0.72 misses by $0.03 [Seeking Alpha]
Medium
Report
Rapport Therapeutics GAAP EPS of -$0.72 misses by $0.03 [Seeking Alpha]
3/10
07:08 am
rapp
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/10
07:00 am
rapp
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/9
11:05 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
Low
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
3/9
11:05 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by TD Cowen.
3/9
07:03 am
rapp
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China [Yahoo! Finance]
Low
Report
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China [Yahoo! Finance]
3/9
07:00 am
rapp
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
Low
Report
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
2/28
01:30 am
rapp
Low
Report
2/24
04:25 pm
rapp
Rapport Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Rapport Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/24
04:05 pm
rapp
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Rapport Therapeutics to Participate in Upcoming Investor Conferences
2/7
02:07 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at
Wall St
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at
Wall St
2/2
07:00 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
1/25
03:05 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at
Wall Stre
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at
Wall Stre
1/17
01:11 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at
Wall St
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) was downgraded by analysts at
Wall St
1/8
07:17 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
1/8
03:38 am
rapp
Assessing Rapport Therapeutics (RAPP) Valuation After Recent Share Price Strength [Yahoo! Finance]
Medium
Report
Assessing Rapport Therapeutics (RAPP) Valuation After Recent Share Price Strength [Yahoo! Finance]
1/7
07:00 am
rapp
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
Medium
Report
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
12/22
11:42 am
rapp
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? [Yahoo! Finance]
Low
Report
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? [Yahoo! Finance]
12/19
08:44 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was given a new $51.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) was given a new $51.00 price target on by analysts at Wells Fargo & Company.
12/19
07:19 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
12/18
07:00 am
rapp
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference